FDA Clears Beckman Coulter’s Stem Cell Analysis System
Beckman Coulter Life Sciences received 510(k) clearance from the FDA to distribute its AQUIOS STEM System in the United States.
Read MorePosted by Andy Lundin | Dec 4, 2023 | Lab Automation, Unknown Origin & Other Cancer Types |
Beckman Coulter Life Sciences received 510(k) clearance from the FDA to distribute its AQUIOS STEM System in the United States.
Read MorePosted by Andy Lundin | Nov 17, 2023 | Transfusion & Transplantation Tests |
Verici Dx signed a licensing agreement with Thermo Fisher on an assay for pre-transplant prognostic testing of early kidney rejection risks.
Read MorePosted by Chris Wolski | Nov 16, 2023 | Diagnostic Technologies |
Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.
Read MorePosted by Andy Lundin | Oct 18, 2023 | Cancer |
The University of Illinois Chicago will participate in a study of a test that screens for a shared cancer signal in patient blood samples.
Read MorePosted by Andy Lundin | Oct 17, 2023 | Hematology & Serology |
FloBio announced that the U.S. FDA has granted Breakthrough Device Designation for its rapid bleeding risk diagnostic test.
Read More